Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.0%

- Check30 days agoChange DetectedUpdated the revision/version from v3.0.2 to v3.1.0, indicating a new release with presumably updated features or fixes, while core content remains unchanged.SummaryDifference0.0%

- Check44 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The old v3.0.1 tag was removed and the Back to Top navigation control was deleted.SummaryDifference0.1%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated to include new studies related to cancer immunotherapy, specifically focusing on lenvatinib and pembrolizumab, while also removing some previously listed location details and related terms.SummaryDifference3%

- Check73 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.